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Assessing Chronic Disease Rates through Automated 
Pharmacy Data 
__________________________________________ 
 
It is well known that people with chronic conditions represent the bulk of all health 
care needs and associated costs. To set appropriate health care strategies, a crucial 
issue for policy makers and health care researchers worldwide is therefore to find 
proper methodologies to assess the number of individuals affected by specific chronic 
illnesses. Thus far, surveillance studies have been largely used to estimate the health 
status of a population because they are fairly inexpensive and data are easy to 
collect. 
 
Recently, the analyses of automated pharmacy data have been proposed as an 
effective means to measure chronic disease within investigated populations. 
Pharmacy data offer several advantages. Prescription data are easily accessible, 
inexpensive, precise, and well coded. In addition, drugs prescribed may be 
associated, to some extent, with specific chronic conditions.  However, few studies 
have validated the accuracy of chronic diseases prevalence rates obtained by this 
methodology. 
 
The existence of a comprehensive, individual-level linkable pharmacy database of the 
approximately 4.0 million inhabitants of Emilia Romagna, a large region in the north 
of Italy, provided a unique opportunity to 1) adopt and apply an existing model of 
chronic condition identification using Italian pharmacy data, 2) determine rates of 
chronic conditions and morbidity within the Emilia Romagna’s population, and 3) 
compare the estimated prevalence rates using pharmacy data with those available 
from a 2000 Emilia Romagna disease surveillance study. This research has been 
jointly conducted by the Department of Health Policy and the Center for Research in 
Medical Education and Health Care, supported through a collaborative agreement 
with the Agenzia Sanitaria Regionale, Regione Emilia Romagna, and Jefferson 
Medical College.1
Using a modified version of the Chronic Disease Score,2 we developed a framework 
that identified the use of discrete pharmaceuticals as an indicator of having a chronic 
condition.  Our framework encompassed important chronic conditions that can be 
tracked through the consumption of prescribed pharmaceuticals under the Italian 
dispensing system. A clinical review was employed to assure that medication classes 
be matched to individuals with chronic conditions and not to incidental users of 
pharmaceuticals. To increase specificity, therapeutic classes associated with chronic 
conditions needed to be mutually exclusive. 
 
A final list of 31 major chronic condition drug groups (CCDGs) was created. This list 
includes primary chronic morbidities, such as cardiovascular diseases and gastric 
disorders, as well as other less recurrent disorders, such as gout and Parkinson’s. 
Algorithms were then tested on pharmaceutical claims data from Emilia-Romagna 
2001 to determine the applicability of our CCDG classification scheme. In 2001, there 
were 55.2 million individual prescriptions. 
 
Applying our model, we found that approximately 1.5 million people (37.1% of the 
population) were identified as having one or more of the 31 CCDGs. The 31 CCDGs 
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accounted for 74.3%of the total number of prescriptions and 76.8% of the total 2001 
drug expenditures. Cardiovascular diseases, rheumatologic conditions, gastric 
disorders, chronic respiratory illnesses, and psychiatric disorders were the most 
frequently occurring chronic diseases. The comparison of rates found through our 
algorithms with those available of a 2000 Emilia Romagna disease surveillance study 
showed, in most cases, similar prevalence of illnesses, particularly for cardiovascular 
diseases, psychiatric disorders, diabetes, benign prostatic hyperplasia, thyroid 
disorders, and malignances. 
 
In conclusion, pharmacy data may be a valuable alternative to estimate the extent to 
which large populations are affected by chronic conditions. The model for identifying 
chronic disease status derived from Italian automated pharmacy data may find 
several applications in the healthcare research field. For example, it could be used to 
compare morbidity levels in different population groups and to determine the extent 
to which the workload of physicians may vary due to patient morbidity differences 
beyond those variations attributable to age and gender. It may help detect level of 
comorbidity. In addition, it may be used to develop risk adjustment models to 
allocate resources in the financing of the Italian health care system.3
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